{"retracted":false,"update":{"timestamp":1459123200000,"doi":"10.1371/journal.pone.0152845","type":"correction"},"doi":"10.1371/journal.pone.0149509","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients"}
